Terns Pharmaceuticals Incorporated is a clinical-stage biopharmaceutical company developing small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, andTERN-201, a vascular adhesion protein-1 inhibitor, are in clinical trials for the treatment of NASH. Terns Pharmaceuticals was incorporated in 2016 and is headquartered in Foster City, CA.
What is Terns Pharmaceuticals's quote symbol?
What is the 52 week high and low for Terns Pharmaceuticals (NASDAQ: TERN)?
How much is Terns Pharmaceuticals stock worth today?
How much is Terns Pharmaceuticals's stock price per share?
What is Terns Pharmaceuticals's Market Cap?